2004-08-01
Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
Publication
Publication
Clinical Chemistry , Volume 50 - Issue 8 p. 1445- 1447
Additional Metadata | |
---|---|
, , , , , , , , , , , , , , , | |
doi.org/10.1373/clinchem.2004.035493, hdl.handle.net/1765/13395 | |
Clinical Chemistry | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Dorssers, L., Grebenchtchikov, N., Brinkman, A., Look, M., Klijn, J., Geurts-Moespot, A., … Sweep, C. G. (2004). Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer. Clinical Chemistry, 50(8), 1445–1447. doi:10.1373/clinchem.2004.035493 |